๐ฃ Today we release the final episode of the Personalized Medicine Podcast series! ๐
We would like to thank all of you for staying with us over the last 3 years! This has been an amazing ride and we appreciate your constant support โค๏ธ๐https://t.co/z71MIrDG5Z
๐ฃ Today we release the final episode of the Personalized Medicine Podcast series! ๐
We would like to thank all of you for staying with us over the last 3 years! This has been an amazing ride and we appreciate your constant support โค๏ธ๐https://t.co/z71MIrDG5Z
๐ฃ We are back with a new episode!
In this episode our host @yagensky sat down with Victor Bustos, the co-founder & COO of Refoxy Pharma, to talk about #academia, #biotech, #VC and how transcription factors can help us combat #aging https://t.co/FdxX56Kwdk
๐ฃ In our new episode, our co-host Aradhana sat down with Ali Aghebat Rafat from Tilibit Nanosystems. Aradhana and Ali discussed #DNAorigami, #DNA barcoding, #biochips and their potential applications in #PersonalizedMedicine. Check it out๐
https://t.co/7kSoVPSMIX
Super excited to share our new @NatureMedicine paper on #precisioncancer!
We use tumor genomes + EHR of >40K cancer patients to identify 458 mutations that predict how a patient responds to specific cancer drugs
Paper https://t.co/PZzJCBBoS9
Great collab w/ @Roche@genentech ๐งต
A special ๐บ ahead of #BCS2022 ๐ซ
The #HCM story is one of ๐ collaboration, innovation and patient-centred care.
Prof Bill McKenna was there from the start and we're honored to share his recollections- from the Coaticook Curse to Myosin inhibitors
https://t.co/8Hz9Fp3lk6 #PMHx
Q: Where can patients fit into research? A: EVERYWHERE! โPatients donโt just help identify the research questions they help find the answers.โ #EULAR2022#gowithus
This week on #TheGeneticsPodcast, @patrick_j_short is joined by @laurence_reid, CEO at @DecibelTx. They discuss delivering novel gene therapies to patients with genetic hearing loss & balance disorders, and the future of tackling hearing issues at birth.
https://t.co/EXCJTjTtjI
Hear our CEO @Jack_O_Meara on a panel discussion @WuXi_AppTec#WuXiHealthcareForum on how Jack and other UK innovators are building on previous scientific advances to advance drug discovery in the UK
Samir Ounzain (@ispiyou), HAYA's CEO & Scientific Co-Founder, recently spoke on targeting long non-coding RNAs for tissue-specific treatment of fibrotic diseases at the RNA World Leaders Conference. More about his perspective in his interview w/ @PMedCast https://t.co/DuUiriug4F
Honored to have been awarded an #ERC Advanced Grant for my project โDeepCellโ. With DeepCell, we aim to model drug effects on organoids via mechanism-constrained deep learning and single cell readouts. PhD and postdoc positions available, please apply :)
https://t.co/X97TYlnyeq